Eleven proteins (immunoglobulins IgG, IgA, IgM, orosomucoid, o^-antiproteinase, haptoglobin, ceruloplasmin, C-reactive protein, transferrin, prealbumin and a 2 -macroglobulin) in human serum were quantitated by a new microparticle-enhanced nephelometric immunoassay. This is a one step competitive assay, based on the nephelometric measurement of light scattered by clusters of protein-coated microparticles specially synthesized for that use. Statistical evaluation (precision, recovery and method comparison) shows that the determination of serum proteins is reliable and accurate for wide ranges of concentration and that the method is quite adequate for strongly increased concentrations. This microparticle-enhanced nephelometric immunoassay appears to offer an alternative method for routine measurement of a great variety of serum proteins at high and intermediate concentrations, which are usually quantified by radial immunodiffusion or conventional immunonephelometry. On account of its sensitivity, it can also be used for the determination of relatively low concentrations of analytes.
Introduction
The synthesis of special microparticles which serve as a solid-phase for antigen-antibody reactions has been reported (1) . These microparticles are monodisperse, hydrophilic and polyfunctional microspheres to which proteins can be covalently bound. The light scattered during agglutination of microparticle-protein conjugates with specific antibodies is measurable with a specially designed nephelometer. Nephelometric measurement of the light scattered during inhibition of this agglutination by free proteins ( fig. 1 ) allows their sensitive quantitation (detection limit lower than 1 g/l) (2) . These studies have led to the development of a new microparticle-enhanced nephelometric immunoassay (Nephelia®, Diagnostics Pasteur, Marnes, France). The present report describes this competitive immunoassay and its application to the quantitation of eleven serum proteins at high and intermediate concentrations in human serum: immunoglobulins IgG, IgA, IgM, orosomucoid, cxi-antiproteinase, haptoglobin, ceruloplasmin, C-reactive protein, transferrin, prealbumin, and a 2 -macroglobulin. Purified proteins (IgG, IgA, IgM, orosomucoid, C-reactive protein, and prealbumin) were kindly supplied by Diagnostics Pasteur or produced (a r antiproteinase, haptoglobin, ceruloplasmin, transferrin and a 2 -macroglobuHn) by the Centre National de Transfusion Sanguine (Paris, France). Heavy chains of IgG (γ) and IgM (μ) were prepared by reduction-alkylation of disulphide bridges and separated by gel filtration (Sephadex G-100, Pharmacia, Uppsala, Sweden) (2) . The purity of all protein preparations was checked by polyacrylamide gel electrophoresis and immunoelectrophoresis.
Goat or rabbit antisera, human standard and control sera were Diagnostics Pasteur products. They were standardized according to the rules of the Societe Franchise de Biologie Clinique approved by the International Federation of Clinical Chemistry. Protein concentrations of standard and control sera were determined by radial immunodiffusion.
Human sera used for precision, recovery and correlation studies were collected from routinely tested patients of the University Hospital of Nancy (France). They were stored at 4 °C or frozen at -20 °C.
Microparticle-protein conjugates
Microparticles were synthesized as previously reported (1 For coating, each protein (0.4 g of IgG heavy chain, 3.3 g IgA, 1.2 g of IgM heavy chain, 0.5 g orosomucoid, 1.1 g αι-antiproteinase, 1.7 g haptoglobin, 2.6 g ceruloplasmin, 3 .0 g C-reactive protein, 0.6 g transferrin, 1.6 g prealbumin, or 3.6 g oc 2 -macroglobulin) was mixed with microparticles (10 g) in 0.1 mol/1 borate buffer pH 8.2, 0.3 mol/1 NaCl (11) and incubated for 18 h at 4°C. 2-Aminoethanol was then added to the binding mixture (0.12 mol/1, 4h) to block unreacted groups of the microparticles. Centrifugation (8000 g l h, 4 °C) on a discontinuous sucrose gradient (200/800 g/1) served to eliminate uncoupled proteins. These uncoupled proteins were measured by conventional immunonephelometry to determine the binding yields. Microparticle-protein conjugates were stored at 4 °C in 0.1 mol/1 borate buffer pH 8.2 containing 0.3 mol/1 NaCl and 0.03 mol/1 NaN 3 .
Procedure of protein determinations
Microparticle-enhanced nephelometric immunoassay of serum proteins is a one step assay: 50 μΐ of microparticle-protein conjugate (0.5 to 2.0 g/1), 10 to 50 μΐ of serum standard (5 or 6 serial dilutions) or diluted (1/100 to 1/1000) sera (control or unknown), and 50 μΐ of prediluted antiserum (1/100 to 1/2000) were mixed with the buffer for nephelometry to give a final volume of 500 μΐ, in disposable microcuvettes (Nephelia cuvette, Diagnostics Pasteur). All dilutions were carried out with an automated dilutor (Hamilton AG, Bonaduz, Switzerland). After 30 min or 1 h at room temperature, light scattering was measured with a specially designed nephelometer (Nephelia N600, Diagnostics Pasteur) (2) equipped with an helium-neon laser (wavelength, 632.8 nm). Spline-smoothed calibration curves ( fig. 1 ) and unknown sample concentrations were calculated with a microcomputer (MBC 885, Sanyo Electric Co., Tokyo, Japan) fitted to the nephelometer.
Evaluation study
The precision of the assays was assessed by measuring normal and pathological concentrations of each protein in human sera, 10, 20 or 30 times during the same assay (within-run precision) and on 5 to 15 different days (between-run precision). The precision was expressed as the coefficient of variation (%).
Recovery studies were carried out by adding increasing amounts of each purified protein to several human sera with a low or normal protein content. One hundred and twenty overloadings were performed in this way, and the results subjected to linear regression analysis (recovered = b + a added). For each protein, the null hypothesis H 0 , intercept b = 0 and slope a = 1, versus the alternative hypothesis HI, intercept b φ Ο and slope a 7* 1, were tested by F (Fisher) and t (Student), respectively.
For comparison of methods, proteins were measured in human sera (1084 sera with widely ranging concentrations for all of the eleven proteins), using radial immunodiffusion (NOR-Partigen, Behring, Marburg, Germany) for IgG, C-reactive protein, and prealbumin, and conventional immunonephelometry (Behring Laser Nephelometry) for IgG, IgA, IgM, orosomucoid, cxi-antiproteinase, haptoglobin, ceruloplasmin, C-reactive protein, transferrin, prealbumin, and a 2 -macroglobulin. The Array System Beckman (Fullerton, CA) was used for IgG, IgA, and transferrin and the Technicon RA-1000 System (Tarrytown, NY) for IgG, IgA, C-reactive protein and transferrin. In addition, C-reactive protein was assayed by fluorescence polarisation (TDx Abbott, Chicago, IL). These assays were carried out strictly following the manufacturer's recommendations. Linear regression analysis was performed for each comparison and a 95% confidence interval was calculated for each correlation coefficient which was used as a measure of the closeness of the association.
Rheumatoid factors were determined in human sera with a latex-slide agglutination test (latex-RF reagent, Behring).
Results

Microparticle-protein conjugates
Copolymerization of acrylic monomers produced microspheres of 235 nm (standard deviation = 3 nm, n = 36) diameter with a mean yield to 63%. Proteins were covalently bound to the microparticles by formation of imine bonds between aldehyde groups of the microsphere and primary amino groups of the proteins (binding yield from 23 to 100%). Microparticle-protein conjugate suspensions remained immunoreactive for six months at least when they were stored at 4 °C with NaN 3 (0.03 mol/1).
Calibration ranges
Decreasing sigmoidal inhibition curves ( fig. 1) were observed for all serum protein determinations. Calibration ranges are given table 1. The limits of each calibration range corresponded to protein concentrations giving light scattering intensity significantly dif-ferent (3 SD upper and 3 SD lower at least) from the light scattered by dispersed microparticle-antigen conjugate alone (0% agglutination) and by aggregated microparticle-antigen conjugate in the presence of antiserum (100% agglutination). Calibration ranges allowed the measurement of normal as well as higher and lower pathological concentrations. Under-estimation of the highest pathological concentrations was avoided by the used inhibition mode. Tables 2 and 3 present the within-run and betweenrun precision results, respectively. The coefficients of variation calculated for large distributions of analyte concentration ranged between 0.7% and 9.5% for the within-run and between 0.7% and 9.6% for the between-run study.
All the analytical recovery results are reported in table 4. Percentage recovery was very close to 100% for all eleven proteins. Statistical studies of the parameters of the linear regression (recovered = b + a added) performed for each protein over a large concentration range showed that the intercepts (b) were never significantly different from 0 (P < 0.05), and the slopes (a) were not significantly different from 1 (P < 0.05), except for IgG (1.03) and C-reactive protein (1.05). with the Array System Beckman (0.86). For some sera, Ceruloplasmin, prealbumin and particularly Creactive protein concentrations were below the limit of detection of the reference methods. These were rejected from our study, although they were measurable by microparticle-enhanced nephelometric immunoassay. No effect (such as a under-or overevaluation of results) of rheumatoid factors, which were found in some sera, was detected in microparticle-enhanced nephelometric immunoassay or in the comparison methods.
Discussion
Radial immunodiffusion (3) and conventional immunonephelometry (4) are commonly used to measure high and intermediate concentrations of serum proteins, but these methods have certain drawbacks. A prolonged diffusion time (from 24 to 48 h) is necessary to obtain reliable results by radial immunodiffusion, and it is ill-adapted for large numbers of samples. Although it is an easy-to-perform method, conventional immunonephelometry has poor sensitiv-ity (1 mg/1), requiring a blank measurement of diluted samples and clarification of turbid samples by pretreatment (5). Furthermore, in conventional immunonephelometry, as in all immunoassays based on an uncompetitive reaction, there is a risk of error when the antigen is in excess.
The microparticle-enhanced nephelometric immunoassay described in this work and used to measure eleven serum proteins, preserves the advantages of conventional immunonephelometry and avoids some of its drawbacks.
It is a highly sensitive assay (detection limit lower than 1 g/l) allowing a great dilution of samples (1/1000 to 1/50000 in the reaction mixture) even for proteins that are present in very low concentrations. Such dilutions removed any interference due to turbidity, sample blank measurement, or sample pretreatment. Although this high sensitivity was not required for the determination of the most serum proteins tested in this work, it permitted the assay of proteins such as ceruloplasmin, prealbumin, and particularly C-reactive protein, whose concentration in some sera used in the comparison study was below the limit of detection of radial imrmmodiffusion and conventional immunonephelometry.
Microparticle-enhanced nephelometric immunoassay is a rapid (30 min to 1 h), fully automatable one step assay, which is suitable for the measurement of a great number of samples (360 per hour), but also easy to use and therefore suitable for emergencies.
The inhibition mode, chosen for the determination of serum proteins, enables analyte underevaluation in antigen excess conditions to be eliminated and provides the possibility of assaying haptens (6, 7) .
Precision studies showed that adequate assay ranges for the quantitation of the eleven tested proteins were easily covered with an accuracy that was comparable to and sometimes better than that of conventional immunonephelometry and radial immunodiffusion (8 -11) , in spite of a larger dilution of samples. Recovery studies showed a close agreement between the theoretical and measured concentrations except for IgG and C-reactive protein (slight over-recovery).
Method comparison indicated a generally strong correlation between the concentrations measured by microparticle-enhanced nephelometric immunoassay and by the reference methods.
Microparticle-enhanced nephelometric immunoassay using microparticles and a nephelometer specifically conceived for that use, thus appears to offer an alternative method for routine determination of a great variety of serum proteins at high and intermediate concentrations. It has been also used to quantify proteins in other biological fluids such as cerebrospinal fluid (2) and milk (12 -15) and other biological molecules with lower concentration (1, 6, 7) . In addition to these above-mentioned reports, this work shows the general applicability of the method.
